Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis

BACKGROUND: Patients receiving hematopoietic stem cell transplantation (HSCT) or chimeric antigen receptor T cell (CAR T-cell) therapy are immunocompromised and at high risk of viral infection, including SAR2-CoV-2 infection. However, the effectiveness and safety of COVID-19 vaccines in these recipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Chenghao, Du, Kelei, Luo, Mingjie, Shen, Kaini, Zhou, Yangzhong, Guo, Kaiyuan, Liu, Yang, Yin, Chen, Li, Yi, Li, Guanqiao, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380660/
https://www.ncbi.nlm.nih.gov/pubmed/35974381
http://dx.doi.org/10.1186/s40164-022-00299-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380660/
https://www.ncbi.nlm.nih.gov/pubmed/35974381
http://dx.doi.org/10.1186/s40164-022-00299-6

Ejemplares similares